Showing results (311-320 of 353) with videos related to
Sort By:
Pageof 36
Nederlands Tijdschrift Voor Geneeskunde|October 29, 2008
[Heart failure in men and women: important differences in the diagnostic workup and treatment]M J Lenzen, A Rosengren, W J M Scholte op Reimer, et al.European Heart Journal|May 6, 1998
Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophyA A Hagège, O Dubourg, M Desnos, et al.Heart (British Cardiac Society)|July 16, 2002
Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathyX Jouven, A Hagege, P Charron, et al.Diabetologia|July 19, 2005
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocolP D Home, S J Pocock, H Beck-Nielsen, et al.Heart (British Cardiac Society)|June 19, 2007
Management of patients with heart failure in clinical practice: differences between men and womenM J Lenzen, A Rosengren, W J M Scholte op Reimer, et al.European Heart Journal|October 3, 2003
Clinical applications of B-type natriuretic peptide (BNP) testingM R Cowie, P Jourdain, A Maisel, et al.American Journal of Human Genetics|November 22, 2000
A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16N Sylvius, F Tesson, C Gayet, et al.Diabetes & Metabolism|September 14, 2010
A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patientsS Jacqueminet, O Barthelemy, F Rouzet, et al.Journal of Medical Genetics|October 4, 2002
Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experienceP Charron, D Héron, M Gargiulo, et al.Clinical Pharmacology and Therapeutics|April 24, 2008
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategyC Lebaudy, J S Hulot, Z Amoura, et al.Pageof 36